Zdrowie i gospodarka · 20/05/1999
FDA Announces Draft Guidance for Platelet Testing and Evaluation of Platelet Substitute Products
The Food and Drug Administration (FDA) has released a draft guidance document that aims to provide updated evaluation criteria for platelets and their substitute products, following recent technological advancements in platelet physiology and biochemistry.